Patent suit against Osteometer (Denmark) withdrawn:
This article was originally published in Clinica
Ostex International (US) has withdrawn legal action against Osteometer (Denmark) in the Netherlands in which it alleged patent infringement of technology incorporated in the bone resorption assay, Osteomark (see Clinica No 663, p 15). Osteometer is working with Cortecs on the development of a doctor's office test for osteoporosis using Osteometer's CrossLaps technology which was the subject of the legal action. Cortecs aims to launch the test this calendar year, says president Dr Michael Flynn.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.